| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |